Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
IC50 value:
Target: mAChR
Properties:
Density: 1.19g/cm3
Boiling Point: 308.5ºC at 760mmHg
Flash Point: 140.4ºC
Vapor Pressure: 0.000676mmHg at 25°C